159 related articles for article (PubMed ID: 12384456)
1. LOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflammation.
Li D; Williams V; Liu L; Chen H; Sawamura T; Antakli T; Mehta JL
Am J Physiol Heart Circ Physiol; 2002 Nov; 283(5):H1795-801. PubMed ID: 12384456
[TBL] [Abstract][Full Text] [Related]
2. Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction.
Li D; Williams V; Liu L; Chen H; Sawamura T; Romeo F; Mehta JL
J Am Coll Cardiol; 2003 Mar; 41(6):1048-55. PubMed ID: 12651056
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1.
Chen H; Li D; Saldeen T; Mehta JL
Am J Physiol Heart Circ Physiol; 2003 May; 284(5):H1612-7. PubMed ID: 12679326
[TBL] [Abstract][Full Text] [Related]
4. p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation.
Gao F; Yue TL; Shi DW; Christopher TA; Lopez BL; Ohlstein EH; Barone FC; Ma XL
Cardiovasc Res; 2002 Feb; 53(2):414-22. PubMed ID: 11827692
[TBL] [Abstract][Full Text] [Related]
5. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
[TBL] [Abstract][Full Text] [Related]
6. Adhesion molecule expression in fibroblasts: alteration in fibroblast biology after transfection with LOX-1 plasmids.
Chen K; Chen J; Liu Y; Xie J; Li D; Sawamura T; Hermonat PL; Mehta JL
Hypertension; 2005 Sep; 46(3):622-7. PubMed ID: 16116044
[TBL] [Abstract][Full Text] [Related]
7. Effect of isoflurane on myocardial ischemia-reperfusion injury through the p38 MAPK signaling pathway.
Zhou Y; Peng DD; Chong H; Zheng SQ; Zhu F; Wang G
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1342-1349. PubMed ID: 30779102
[TBL] [Abstract][Full Text] [Related]
8. LOX-1 pathway affects the extent of myocardial ischemia-reperfusion injury.
Kataoka K; Hasegawa K; Sawamura T; Fujita M; Yanazume T; Iwai-Kanai E; Kawamura T; Hirai T; Kita T; Nohara R
Biochem Biophys Res Commun; 2003 Jan; 300(3):656-60. PubMed ID: 12507499
[TBL] [Abstract][Full Text] [Related]
9. Activation of lectin-like oxidized low-density lipoprotein receptor-1 induces apoptosis in cultured neonatal rat cardiac myocytes.
Iwai-Kanai E; Hasegawa K; Sawamura T; Fujita M; Yanazume T; Toyokuni S; Adachi S; Kihara Y; Sasayama S
Circulation; 2001 Dec; 104(24):2948-54. PubMed ID: 11739311
[TBL] [Abstract][Full Text] [Related]
10. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
[TBL] [Abstract][Full Text] [Related]
11. LOX-1 abrogation reduces myocardial ischemia-reperfusion injury in mice.
Hu C; Chen J; Dandapat A; Fujita Y; Inoue N; Kawase Y; Jishage K; Suzuki H; Li D; Hermonat PL; Sawamura T; Mehta JL
J Mol Cell Cardiol; 2008 Jan; 44(1):76-83. PubMed ID: 18022184
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
[TBL] [Abstract][Full Text] [Related]
13. Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells.
Mehta JL; Chen J; Yu F; Li DY
Cardiovasc Res; 2004 Nov; 64(2):243-9. PubMed ID: 15485683
[TBL] [Abstract][Full Text] [Related]
14. Cpg-ODN, a TLR9 Agonist, Aggravates Myocardial Ischemia/Reperfusion Injury by Activation of TLR9-P38 MAPK Signaling.
Xie L; He S; Kong N; Zhu Y; Tang Y; Li J; Liu Z; Liu J; Gong J
Cell Physiol Biochem; 2018; 47(4):1389-1398. PubMed ID: 29929196
[TBL] [Abstract][Full Text] [Related]
15. LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells.
Li D; Liu L; Chen H; Sawamura T; Ranganathan S; Mehta JL
Circulation; 2003 Feb; 107(4):612-7. PubMed ID: 12566375
[TBL] [Abstract][Full Text] [Related]
16. IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury.
Altavilla D; Deodato B; Campo GM; Arlotta M; Miano M; Squadrito G; Saitta A; Cucinotta D; Ceccarelli S; Ferlito M; Tringali M; Minutoli L; Caputi AP; Squadrito F
Cardiovasc Res; 2000 Aug; 47(3):515-28. PubMed ID: 10963724
[TBL] [Abstract][Full Text] [Related]
17. Role of p38 MAP kinase in postcapillary venule leukocyte adhesion induced by ischemia/reperfusion injury.
Johns DG; Ao Z; Willette RN; Macphee CH; Douglas SA
Pharmacol Res; 2005 May; 51(5):463-71. PubMed ID: 15749461
[TBL] [Abstract][Full Text] [Related]
18. E-selectin in the pathogenesis of experimental myocardial ischemia-reperfusion injury.
Altavilla D; Squadrito F; Ioculano M; Canale P; Campo GM; Zingarelli B; Caputi AP
Eur J Pharmacol; 1994 Jan; 270(1):45-51. PubMed ID: 7512508
[TBL] [Abstract][Full Text] [Related]
19. Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCepsilon-MAPK-p90RSK, and Rho-kinase pathway.
Kobayashi N; Hara K; Tojo A; Onozato ML; Honda T; Yoshida K; Mita S; Nakano S; Tsubokou Y; Matsuoka H
Hypertension; 2005 Apr; 45(4):538-44. PubMed ID: 15710785
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of 12/15 lipoxygenase by baicalein reduces myocardial ischemia/reperfusion injury via modulation of multiple signaling pathways.
Song L; Yang H; Wang HX; Tian C; Liu Y; Zeng XJ; Gao E; Kang YM; Du J; Li HH
Apoptosis; 2014 Apr; 19(4):567-80. PubMed ID: 24248985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
